enkephalin, ser(2), leu(5), thr(6)- has been researched along with norketobemidone in 1 studies
Studies (enkephalin, ser(2), leu(5), thr(6)-) | Trials (enkephalin, ser(2), leu(5), thr(6)-) | Recent Studies (post-2010) (enkephalin, ser(2), leu(5), thr(6)-) | Studies (norketobemidone) | Trials (norketobemidone) | Recent Studies (post-2010) (norketobemidone) |
---|---|---|---|---|---|
224 | 0 | 5 | 5 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christensen, CB; Christrup, LL; Kristensen, K; Nielsen, LC | 1 |
1 other study(ies) available for enkephalin, ser(2), leu(5), thr(6)- and norketobemidone
Article | Year |
---|---|
The mu1 and mu2 opioid receptor binding of ketobemidone, norketobemidone and 3-dimethylamino-1,1-diphenylbutene.
Topics: Allylamine; Analgesics, Opioid; Animals; Binding, Competitive; Cattle; Caudate Nucleus; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Humans; Isonipecotic Acids; Meperidine; Parasympatholytics; Phenols; Receptors, Opioid, delta; Receptors, Opioid, mu | 1996 |